J B Chemicals and Pharmaceuticals Ltd
Dr. Milind Joshi earned his Ph.D. in Analytical Chemistry in 1989 from the University of Mumbai. He is the recipient of “Outstanding Pharmaceutical Analyst Award 2006” by IDMA. Dr. Joshi is Chairman of the United States Pharmacopeia (USP) – South Asia Stakeholder Forum and was a member of the Nominating Committee of USP too. Currently, Dr. Joshi is Chairman of IDMA’s Quality and Technical Committee.
This person is not in any offices
J B Chemicals and Pharmaceuticals Ltd
J. B. Chemicals & Pharmaceuticals Limited is a pharmaceutical company. The Company manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs). The Company's business segments include domestic formulation business, exports and API business. The Company markets various contrast media products in India, such as Contrapaque (Iohexol), Lek Pamidol (Iopamidol), Trazograf (Diatrazoic acid), Trazogastro - Oral contrast (Diatrazoic acid), Magnilek Injection (Gadopentatic acid) and Cardiolek Injection (Iodixanol). The Company's brands for the Indian pharmaceutical market include Metrogyl (Metronidazole), Nicardia (Nifedipine), Rantac (Ranitidine), Dicloran (Diclofenac Sodium), OF (Ofloxacin), Cilacar (Cilnidipine) and Zecuf herbal. It manufactures generic products for the regulated markets and branded formulations for the emerging markets. It manufactures various APIs, such as Cilnidipine, Diclofenac Acid and Gadopentatic acid.